Cargando…

PTPRO is a therapeutic target and correlated with immune infiltrates in pancreatic cancer

As a member of protein tyrosine phosphatases (PTPs), the protein tyrosine phosphatase receptor type O (PTPRO) has attracted increasing attention for its important roles in cell signaling. Currently, the roles of PTPRO in human cancers remain elusive. Herein, we performed bioinformatic analyses and r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Xuben, Du, Jintong, Fang, Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734421/ https://www.ncbi.nlm.nih.gov/pubmed/35003364 http://dx.doi.org/10.7150/jca.64661

Ejemplares similares

PTPRO predicts patient prognosis and correlates with immune infiltrates in human clear cell renal cell carcinoma
por: Gan, Jinfeng, et al.
Publicado: (2020)

PTPRO-mediated autophagy prevents hepatosteatosis and tumorigenesis
por: Zhang, Wenjie, et al.
Publicado: (2015)

Comprehensively Analyze the Prognosis Significance and Immune Implication of PTPRO in Lung Adenocarcinoma
por: Lin, Zhimin, et al.
Publicado: (2023)

Structure-Based Design of 2-Aminopurine Derivatives as CDK2 Inhibitors for Triple-Negative Breast Cancer
por: Liang, Hanzhi, et al.
Publicado: (2022)

PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy
por: Huang, Yi-Teng, et al.
Publicado: (2013)

PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism
por: Dai, Weixing, et al.
Publicado: (2022)

The tyrosine phosphatase PTPRO sensitizes colon cancer cells to anti-EGFR therapy through activation of SRC-mediated EGFR signaling
por: Asbagh, Layka Abbasi, et al.
Publicado: (2014)

Tyrosine Phosphatase PTPRO Deficiency in ERBB2-Positive Breast Cancer Contributes to Poor Prognosis and Lapatinib Resistance
por: Dong, Hongmei, et al.
Publicado: (2022)

PTPRO-related CD8(+) T-cell signatures predict prognosis and immunotherapy response in patients with breast cancer
por: Dong, Hongmei, et al.
Publicado: (2022)

Study on the Relationship Between PTPRO Methylation in Plasma and Efficacy Neoadjuvant Chemotherapy in Patients with Early Breast Cancer
por: Liu, Xiang-Wei, et al.
Publicado: (2023)

PTPRO represses ERBB2-driven breast oncogenesis by dephosphorylation and endosomal internalization of ERBB2
por: Dong, H, et al.
Publicado: (2017)

Age-related decline in hippocampal tyrosine phosphatase PTPRO is a mechanistic factor in chemotherapy-related cognitive impairment
por: Yao, Zhimeng, et al.
Publicado: (2023)

Aberrant PTPRO methylation in tumor tissues as a potential biomarker that predicts clinical outcomes in breast cancer patients
por: Li, Shao-ying, et al.
Publicado: (2014)

SNAI1 is a prognostic biomarker and correlated with immune infiltrates in gastrointestinal cancers
por: Fang, Jiaying, et al.
Publicado: (2020)

CRYP-2/cPTPRO is a neurite inhibitory repulsive guidance cue for retinal neurons in vitro
por: Stepanek, Laurie, et al.
Publicado: (2001)

PTPRO knockdown protects against inflammation in hemorrhage shock-induced lung injury involving the NF-κB signaling pathway
por: Huan, Zhirong, et al.
Publicado: (2022)

Protein tyrosine phosphatase receptor type O (PTPRO) knockdown enhances the proliferative, invasive and angiogenic activities of trophoblast cells by suppressing ER resident protein 44 (ERp44) expression in preeclampsia
por: Yang, Yang, et al.
Publicado: (2021)

Phospholipase A/acyltransferase 4 is a prognostic biomarker and correlated with immune infiltrates in pancreatic cancer
por: Li, Tian-Hao, et al.
Publicado: (2022)

MiR-6869-5p Induces M2 Polarization by Regulating PTPRO in Gestational Diabetes Mellitus
por: Wang, Pingping, et al.
Publicado: (2021)

Prognostic alternative splicing signature reveals the landscape of immune infiltration in Pancreatic Cancer
por: Wang, Lin, et al.
Publicado: (2020)

GABRP is a potential prognostic biomarker and correlated with immune infiltration and tumor microenvironment in pancreatic cancer
por: Yang, Yihui, et al.
Publicado: (2022)

Notch1/2/3/4 are prognostic biomarker and correlated with immune infiltrates in gastric cancer
por: Hu, Jian, et al.
Publicado: (2020)

CXCL5 overexpression predicts a poor prognosis in pancreatic ductal adenocarcinoma and is correlated with immune cell infiltration
por: Zhang, Ronghua, et al.
Publicado: (2020)

MiR-6803-5p Promotes Cancer Cell Proliferation and Invasion via PTPRO/NF-κB Axis in Colorectal Cancer
por: Yan, Shushan, et al.
Publicado: (2019)

Protein tyrosine phosphatase receptor type O (Ptpro) regulates cerebellar formation during zebrafish development through modulating Fgf signaling
por: Liao, Wei-Hao, et al.
Publicado: (2013)

PD-L1 correlated gene expression profiles and tumor infiltrating lymphocytes in pancreatic cancer
por: Li, Jiajin, et al.
Publicado: (2021)

Epigenetically silenced PTPRO functions as a prognostic marker and tumor suppressor in human lung squamous cell carcinoma
por: Ming, Fei, et al.
Publicado: (2017)

CFP is a prognostic biomarker and correlated with immune infiltrates in Gastric Cancer and Lung Cancer
por: Cui, Guoliang, et al.
Publicado: (2021)

Targeting histone deacetylases for cancer therapy: Trends and challenges
por: Liang, Tao, et al.
Publicado: (2023)

Ceruloplasmin correlates with immune infiltration and serves as a prognostic biomarker in breast cancer
por: Chen, Fei, et al.
Publicado: (2021)

Bioinformatic Analysis of Correlation between Immune Infiltration and COVID-19 in Cancer Patients
por: Huang, Xin, et al.
Publicado: (2020)

Neurexophilin 4 is a prognostic biomarker correlated with immune infiltration in bladder cancer
por: Sun, Xianchao, et al.
Publicado: (2022)

nc‐RNA‐mediated high expression of CDK6 correlates with poor prognosis and immune infiltration in pancreatic cancer
por: Zhao, Yu‐Xuan, et al.
Publicado: (2022)

Identification of Candidate Therapeutic Target Genes and Profiling of Tumor-Infiltrating Immune Cells in Pancreatic Cancer via Integrated Transcriptomic Analysis
por: Ding, Wei, et al.
Publicado: (2022)

Cathepsin a upregulation in glioma: A potential therapeutic target associated with immune infiltration
por: Zhang, Ming, et al.
Publicado: (2022)

APOE Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Papillary Thyroid Carcinoma
por: Lin, Xu, et al.
Publicado: (2022)

CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer
por: Hou, Weiyan, et al.
Publicado: (2022)

Hepcidin Upregulation in Lung Cancer: A Potential Therapeutic Target Associated With Immune Infiltration
por: Fan, Yumei, et al.
Publicado: (2021)

Prognostic-Related Biomarkers in Pancreatic Ductal Adenocarcinoma Correlating with Immune Infiltrates Based on Proteomics
por: Kou, Yan-qi, et al.
Publicado: (2023)

YAP1 is a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Pancreatic Cancer
por: Sun, Kai, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7ap54f5bhjpkbehba5ejbmvbki